Showing results (351-360 of 358) with videos related to
Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 358 results.
Scientific Reports|July 2, 2025
Synergistic strategy of riboflavin and lipoids to bioengineer resin dentin hybrid layerWong Er-Vin, Yip Chun Marn, Wong Siew Shuai, et al.Drug Discovery Today|June 4, 2013
Model-based drug discovery: implementation and impactSandra A G Visser, Malin Aurell, Rhys D O Jones, et al.American Journal of Respiratory and Critical Care Medicine|August 19, 2020
A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in AsthmaIoannis Psallidas, Vibeke Backer, Piotr Kuna, et al.Science (New York, N.Y.)|August 3, 2019
The geologic history of seawater oxygen isotopes from marine iron oxidesNir Galili, Aldo Shemesh, Ruth Yam, et al.The Journal of Pharmacology and Experimental Therapeutics|August 4, 2009
(R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of actionAnders Lehmann, Madeleine Antonsson, Ann Aurell Holmberg, et al.European Journal of Heart Failure|July 20, 2023
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fractionLars H Lund, Carolyn S P Lam, Patricia E Pizzato, et al.Nature Communications|January 3, 2026
Autologous cell therapy with CD133+ bone marrow-derived stem cells for Asherman Syndrome: a phase 1/2 trialXavier Santamaria, María Pardo-Figuerez, Javier González-Fernández, et al.Drug Design, Development and Therapy|September 7, 2022
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of AsthmaMagnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, et al.Pageof 36